These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
868 related articles for article (PubMed ID: 31109331)
1. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia. He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533 [TBL] [Abstract][Full Text] [Related]
3. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia. Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742 [TBL] [Abstract][Full Text] [Related]
4. High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics. He X; Hu J; Yan C; Liu X; Zhao Y; Yang P; Wang J; Li S; Zhang W; Dong G; Zhang W; Jing H Cancer Biomark; 2023; 36(3):221-230. PubMed ID: 36938721 [TBL] [Abstract][Full Text] [Related]
5. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia. Shi JL; Fu L; Wang WD Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia. Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia. Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1. Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066 [TBL] [Abstract][Full Text] [Related]
11. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Liu Y; Lu R; Cui W; Pang Y; Liu C; Cui L; Qian T; Quan L; Dai Y; Jiao Y; Pan Y; Ye X; Shi J; Cheng Z; Fu L Cancer Gene Ther; 2020 Feb; 27(1-2):38-44. PubMed ID: 30923336 [TBL] [Abstract][Full Text] [Related]
12. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885 [TBL] [Abstract][Full Text] [Related]
13. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia. Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the FUT family in acute myeloid leukemia. Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266 [TBL] [Abstract][Full Text] [Related]
15. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
16. Higher Expression of Chen C; Chen Z; Chio CL; Zhao Y; Li Y; Liu Z; Jin Z; Wu X; Wei W; Zhao Q; Li Y Technol Cancer Res Treat; 2021; 20():15330338211052152. PubMed ID: 34738847 [No Abstract] [Full Text] [Related]
17. High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia. Fu L; Fu H; Qiao J; Pang Y; Xu K; Zhou L; Wu Q; Li Z; Ke X; Xu K; Shi J Cancer Sci; 2017 Sep; 108(9):1850-1857. PubMed ID: 28670859 [TBL] [Abstract][Full Text] [Related]
18. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients]. Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374 [No Abstract] [Full Text] [Related]
19. Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer. Feng LY; Li L J Ovarian Res; 2020 Mar; 13(1):35. PubMed ID: 32228639 [TBL] [Abstract][Full Text] [Related]
20. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia. Jinlong S; Lin F; Yonghui L; Li Y; Weidong W PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]